Break the Bank is a game show created by Richard S. Kline. It aired in syndication from September 16, 1985 to May 23, 1986, with repeats airing until September 12. It was not related to two previous ...

It’s the year of Britpop revival. In last night’s case, Gene reunited at Brudenell Social Club in Leeds to play a two-hour set. Gene — singer Martin Rossiter, guitarist Steve Mason, bassist Kevin ...

Scientists report the first therapy to slow the deadly brain disease. A one-time gene therapy treatment has shown remarkable success in slowing the progression of Huntington's disease in a preliminary ...

The Urban Prepper explores 2014 Bloopers with focus on practicality, preparedness, and survival strategies. Trump set to bail out Argentina, irking some in ‘America First’ camp ICE Flags Six Suspects ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Gene Sauerwine, Jr., 45 of Wilkes-Barre, passed away at home after a lengthy illness on Sunday, September 21, 2025. Gene is already deeply missed by his parents Eugene and Cathy (Williamson) Sauerwine ...

At the WIRED Health summit last week, Harvard biochemist and gene-editing pioneer David Liu said that later this year his lab plans to report on a single gene-editing strategy that could treat many ...

AUSTIN (KXAN) — An exceptionally rare and fatal genetic disease may finally have a solution. Huntington’s Disease affects one in ten to twenty thousand Americans. The disease is a mixture of dementia ...

Duchenne muscular dystrophy (DMD) is a neuromuscular disorder that results from mutations in the DMD gene. Gene therapies for DMD change genetic material in a person’s body to treat this condition.

An experimental gene therapy has become the first treatment to successfully slow the progression of Huntington’s disease. While the findings are still preliminary, the approach could be a major ...

A new gene therapy has slowed the progression of Huntington's disease by as much as 75%. Known as AMT-130, it is delivered via brain surgery, and a single dose is expected to last someone's whole life ...